ThursdayDec 08, 2022 12:12 pm

Doing Crossword Puzzles Helps Sharpen Memory Better Than Computer Games

Researchers have discovered that crossword puzzles help to better sharpen memory in older individuals suffering from mild cognitive impairment, in comparison to computer games. While crossword puzzles are popularly used, no research has systematically studied them and their association with mild cognitive impairment until now. Mild cognitive impairment is known to heighten the risk of an individual developing dementia. The study was led by Professor D.P. Devenand of Columbia University and Professor Murali Doraiswamy, director of the Neurocognitive Disorders Program at Duke University School of Medicine. For their study, the researchers recruited more than 100 participants suffering from mild cognitive…

Continue Reading

WednesdayDec 07, 2022 1:33 pm

Research Suggests That Gum Disease May Cause Alzheimer’s

Alzheimer’s is a common type of dementia that usually starts with mild memory loss before progressing to loss of the ability to carry on a conversation with another person. Recent studies have found that the disease, which affects parts of the brain that control memory, thought and language, is actually an infection. One such study suggested that gum disease, which starts as bacterial growth in an individual’s mouth, may be the bacterial culprit behind this degenerative condition. This comes after scientists discovered Porphyromonas gingivalis in the brains of deceased individuals who suffered from Alzheimer’s. Porphyromonas gingivalis is a pathogen that…

Continue Reading

TuesdayDec 06, 2022 12:50 pm

Teens Suffering from Concussions Could Benefit from Screen Time

As mobile phones, social media and apps have taken center stage in our lives, several experts have become increasingly worried about the amount of time the average person spends looking at screens. On average, people around the world spend nearly seven hours daily on their screens, with the average American spending an average of seven hours and four minutes every day on their screens. Gen Z, the generation that grew up with the internet, spends up to nine hours per day looking at screens. But while studies show that too much screen time can have negative effects on adolescents and…

Continue Reading

MondayDec 05, 2022 12:29 pm

Research Recommends Reduction of Pediatric Brain Irradiation During Cancer Treatment

According to Cancer.org, slightly more than 10,000 children under the age of 15 will be diagnosed with pediatric cancer by the end of the year. While more than 80% of children with cancer in high-income countries such as the United States are treated successfully, data shows that these cancer treatments are often a double-edged sword. A recent study published in the “Journal of the National Cancer Institute” revealed that pediatric cancer patients experience significant premature aging compared to counterparts in the same age group who did not have pediatric cancer. Cancer treatments such as abdominal radiation and chemotherapy were found…

Continue Reading

MondayDec 05, 2022 9:45 am

MetAlert Inc. (MLRT) Announces Canadian Distributor Launch of Award-Winning 4G GPS SmartSole Medical Monitoring Device for Alzheimer’s, Dementia, and Autism

ARPA-H is investing a billion dollars to encourage cutting-edge research for Alzheimer's, supporting bold ideas to pursue and drive new biomedical breakthroughs The Department of Health and Human Services is investing in research and technology to help keep Alzheimer's patients in their homes longer, train caregivers to support them, and educate Americans about Alzheimer's early warning signs – all of which MetAlert provides products and solutions for The Alzheimer’s Disease diagnostic and therapeutic market is expected to reach an estimated $9.6 billion by 2027 MetAlert (OTC: MLRT), a pioneer in location-sensitive health monitoring devices and wearable technology products, has announced…

Continue Reading

FridayDec 02, 2022 11:59 am

Research Discovers That Survivors of Pediatric Cancer Are Prone to Premature Aging

Every year, an estimated 400 children and adolescents aged 19 and under are diagnosed with cancer. Leukemia, brain tumors, solid tumors such as neuroblastomas and lymphomas tend to be the most common types of pediatric cancer, with more than 80% of patients in high-income nations such as the United States receiving treatment. Even though pediatric cancer treatment can be quite cost intensive, childhood cancer can generally be cured via surgery, radiotherapy, chemotherapy and generic medicines. However, a recent study has revealed that patients who survive pediatric cancer aren’t completely out of the woods even after they are in remission. The…

Continue Reading

ThursdayDec 01, 2022 9:00 am

Odyssey Health, Inc. (ODYY) To Give Corporate Update at Scheduled Annual Meeting of Stockholders in January 2023

Odyssey is set to hold its Annual Meeting of Stockholders on January 12, 2023 The meeting promises an excellent podium to update shareholders on the company’s progress throughout the 2022 calendar year as well as its plans for the future Odyssey has so far achieved vital milestones such as progress in its ONP-002 novel compound on the treatment of concussions, patent protection filing for its Nasal Device, and the expansion of its executive team It looks to take advantage of the meeting to draw stockholders' views and opinions on specific topics while also offering them a platform to contribute to…

Continue Reading

WednesdayNov 30, 2022 12:38 pm

Researchers Look to AI to Improve Organ Transplant Processes

Artificial intelligence (AI) is a relatively novel technology with the potential to revolutionize not just the IT industry but a whole slew of sectors. This technology leverages the ability of computer algorithms to analyze enormous data sets and learn from features or patterns in the data. AI technology is now being deployed in various industries, including the medical field. A few years ago, researchers found that AI systems could diagnose eye diseases as accurately as trained physicians. Earlier this year, further research also revealed that AI and machine learning could be used to diagnose heart diseases by analyzing the network…

Continue Reading

TuesdayNov 29, 2022 12:00 pm

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Pipeline Focused on Creating Innovative Immunotherapeutic Products for Treating Underserved Infectious and Autoimmune Diseases

In collaboration with Max Planck Institute for Multidisciplinary Sciences (“MPI”) and the University Medical Center Göttingen, BiondVax is developing a pipeline of NanoAb therapies The company’s co-lead scientific research collaborator, Professor Dr. Dirk Görlich, director at MPI, was awarded the inaugural $1.4 million World Laureates Association (“WLA”) Prize in Life Sciences or Medicine for his work describing protein transport within the cell The global market for autoimmune disorder therapies is expected to reach $90.7 billion by 2024; The global market for infectious disease therapeutics is expected to reach $167 billion by 2030 BiondVax Pharmaceuticals (NASDAQ: BVXV) is a biotechnology company…

Continue Reading

TuesdayNov 29, 2022 10:30 am

Odyssey Health, Inc. (ODYY) Development of Neuropharmaceuticals for TBIs and CNS Maladies, Portends Competitiveness in Area of Unmet Medical Needs

A growing chorus of concerns about brain concussions resulting from athletic events is helping to propel new interest in developing pharmaceuticals to treat this “unmet medical need” Concussion treatments have largely focused on simple rest, but medical product developer Odyssey Health Inc. is developing a potential treatment to reduce brain inflammation so needed therapy can get to the site of a brain injury Odyssey is also developing solutions for other central nervous system troubles, such as the highly fatal childhood disease Niemann-Pick type C, and nerve gas exposure sickness The neuropharmaceutical market is forecast to have a great deal of…

Continue Reading

Official NewsWire Relationships

BIO Informa DGE Dynamic Global Events DTC Healthcare Conference Kiasco Reasearch Nexus Conferences Octane

BioMedWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000